ODTUnknown

Odonate Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Odonate Therapeutics, Inc. (ODT), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are ODT insiders buying or selling?

Odonate Therapeutics, Inc. insiders reported 40 open-market buys ($138.8M) and 5 sells ($20.3M) across 45 Form 4 filings — a net buying position of $118.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Dec 10, 2021)

Total Form 4 filings
45
SEC EDGAR
Insider filers
6
Insider buys (40)
$138.8M
Insider sells (5)
$20.3M

Insider sentiment

Net buying

Net insider flow of $118.5M in net buying.

Recent ODT insider transactions

DateInsiderRoleTypeSharesPriceValue
Dec 10, 2021EcoR1 Capital, LLC10% OwnerSale5.7M$1.65$9.4M
Nov 24, 2021Joseph Lewis10% OwnerSale400.0K$1.56$623.3K
Nov 20, 2021Aaron I. DavisDirector, 10% OwnerSale1.2M$2.08$2.5M
Nov 20, 2021Joseph LewisDirector, 10% OwnerSale1.0M$2.06$2.1M
Nov 19, 2021Kevin C TangChief Executive OfficerSale2.7M$2.09$5.7M
Dec 31, 2020Craig A JohnsonDirectorPurchase3.0K$17.00$51.0K
Dec 30, 2020Boxer Capital, LLCDirector, 10% OwnerPurchase400.0K$17.16$6.9M
Dec 30, 2020Aaron I. DavisDirector, 10% OwnerPurchase400.0K$17.16$6.9M
Dec 23, 2020TANG KEVIN CChief Executive OfficerPurchase275.8K$15.16$4.2M
Sep 30, 2020Aaron I. DavisDirector, 10% OwnerPurchase215.2K$13.63$2.9M
Sep 30, 2020Boxer Capital, LLCDirector, 10% OwnerPurchase215.2K$13.63$2.9M
Sep 30, 2020TANG KEVIN CChief Executive OfficerPurchase110.9K$13.13$1.5M
Sep 9, 2020Aaron I. DavisDirector, 10% OwnerPurchase225.0K$14.98$3.4M
Sep 9, 2020Boxer Capital, LLCDirector, 10% OwnerPurchase225.0K$14.98$3.4M
Sep 1, 2020Boxer Capital, LLCDirector, 10% OwnerPurchase1.4M$14.25$20.0M
Sep 1, 2020Aaron I. DavisDirector, 10% OwnerPurchase1.4M$14.25$20.0M
Sep 1, 2020TANG KEVIN CChief Executive OfficerPurchase1.1M$14.25$15.0M
Jun 28, 2019Boxer Capital, LLC10% OwnerPurchase384.6K$26.00$10.0M
Jun 28, 2019Jeff L VacircaDirectorPurchase19.2K$26.00$500.0K
Jun 28, 2019TANG KEVIN CChief Executive OfficerPurchase769.2K$26.00$20.0M
Jun 19, 2019TANG KEVIN CChief Executive OfficerPurchase50.0K$26.15$1.3M
Jun 10, 2019TANG KEVIN CChief Executive OfficerPurchase76.3K$27.36$2.1M
Jun 5, 2019TANG KEVIN CChief Executive OfficerPurchase93.7K$24.92$2.3M
Mar 11, 2019TANG KEVIN CChief Executive OfficerPurchase140.0K$18.26$2.6M
Mar 7, 2019Jeff L VacircaDirectorPurchase3.0K$17.00$51.0K

Showing the 25 most recent of 45 Form 4 filings for Odonate Therapeutics, Inc..

Most active ODT insiders

  • TANG KEVIN C25 filings
  • Boxer Capital, LLC9 filings
  • Aaron I. Davis7 filings
  • Jeff L Vacirca2 filings
  • Craig A Johnson1 filing

Ask anything about ODT insider activity

Use Trabud's AI agent to query Odonate Therapeutics, Inc.'s Form 4 history in plain English — "Show me ODT CEO purchases this year" or compare it against any other ticker.

Open the AI agent

ODT insider trading FAQ

Are Odonate Therapeutics, Inc. insiders buying or selling?

Across 45 SEC Form 4 filings, Odonate Therapeutics, Inc. (ODT) insiders reported 40 open-market purchases totaling $138.8M and 5 sales totaling $20.3M. That is a net buying position of $118.5M.

How many insiders trade ODT stock?

6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Odonate Therapeutics, Inc.. The most recent filing was accepted on Dec 10, 2021.

Where does Trabud get ODT insider trading data?

All ODT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content